Skip to main content
Oncotarget logoLink to Oncotarget
. 2022 Dec 6;13:1307. doi: 10.18632/oncotarget.28317

Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study

Silvia P Corona 1,, Fabiola Giudici 1,2, Guy Jerusalem 3, Eva Ciruelos 4, Carla Strina 5, Marianna Sirico 6, Ottavia Bernocchi 1, Manuela Milani 5, Martina Dester 5, Nicoletta Ziglioli 5, Giuseppina Barbieri 5, Valeria Cervoni 5, Filippo Montemurro 7, Daniele Generali 1,5
PMCID: PMC9726201  PMID: 36473136

This article has an addendum: Written informed consent was obtained from all patients. The study protocol was approved by an independent ethics committee or institutional review board at each site.

Original article: Oncotarget. 2020; 11:2172–2181. 2172-2181. https://doi.org/10.18632/oncotarget.27612


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES